(Q45861566)

17 December 2017

title

Prophylaxis in factor IX deficiency product and patient variation (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00751.X

24 December 2023

1 reference

Mononine Study Group

4

1 reference

17 December 2017

C. T. Kisker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694518

24 December 2023

A. Eisberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694518

24 December 2023

B. Schwartz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694518

24 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12694518

24 December 2023

publication date

1 May 2003

1 reference

17 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2516.2003.00751.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00751.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2516.2003.00751.x

24 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00751.X

24 December 2023

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

279-284

1 reference

17 December 2017

Haemophilia prophylaxis in young patients--a long-term follow-up

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00751.X

Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00751.X

Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00751.X

Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00751.X

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00751.X

Prophylactic therapy for hemophilia in a developing country, Turkey

24 December 2023

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00751.X

Treatment of Hemophilia B with a New Clotting-Factor Concentrate

24 December 2023

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00751.X

24 December 2023

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017